Venky's net profit surges 216% to ₹50 crore in Q1FY27
Venky's (India) Limited reported a net profit of ₹49.99 crore for Q1FY27, up 216% YoY. Revenue rose 29% to ₹1,118.38 crore, driven by strong performance in poultry, animal health, and oilseed segments.

*this image is generated using AI for illustrative purposes only.
Venky's (India) Limited reported a net profit of ₹49.99 crore for the quarter ended June 30, 2026, marking a 216% year-on-year increase from ₹15.83 crore in the same period last year. The company’s revenue from operations grew 29% to ₹1,118.38 crore, driven by improved volumes and better realizations across its poultry, animal health, and oilseed segments. This robust performance underscores the effectiveness of cost optimization measures despite higher feed prices in the poultry business, significantly boosting shareholder value through expanded margins.
The Board of Directors approved the audited financial results for Q1FY27 in a meeting held on August 11, 2026. The results were reviewed by the Audit Committee and submitted to statutory auditors Sudit K. Parekh & Co. LLP in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The financial statements were prepared in accordance with Indian Accounting Standard 34 (IND AS 34).
Segment Performance
All three business segments contributed to the top-line growth and profitability:
| Segment | Revenue (₹ Cr) | Profit Before Tax & Interest (₹ Cr) |
|---|---|---|
| Poultry and Poultry Products | 516.89 | 16.25 |
| Animal Health Products | 113.67 | 30.31 |
| Oilseed | 527.91 | 30.96 |
The Poultry and Poultry Products segment generated revenue of ₹516.89 crore, up from ₹475.66 crore in Q1FY26, with a pre-tax profit of ₹16.25 crore compared to a loss of ₹5.66 crore previously. The improvement was attributed to better volume and realization, offsetting higher feed costs. The Animal Health Products segment saw revenue rise to ₹113.67 crore from ₹96.98 crore, posting a profit of ₹30.31 crore due to higher volume and an improved product mix. The Oilseed segment recorded revenue of ₹527.91 crore, a significant jump from ₹318.02 crore, with profits reaching ₹30.96 crore thanks to cost optimization.
Financial Highlights
Total income stood at ₹1,131.87 crore, while total expenses were ₹1,062.60 crore. Other income decreased slightly to ₹13.49 crore from ₹11.69 crore in the prior year quarter. Finance costs remained controlled at ₹3.94 crore. Earnings per share (basic) were ₹35.49, compared to ₹11.24 in Q1FY26.
What the Numbers Show
The most notable aspect of Venky’s Q1FY27 performance is the divergence between revenue growth and expense management. While revenue grew by nearly 30%, total expenses increased by only 24%, leading to a substantial expansion in operating margins. The Oilseed segment, which now contributes the largest share of revenue (47% of total operations), has become a key profit driver, more than doubling its contribution to pre-tax profits. This shift highlights the company’s successful diversification away from reliance solely on the cyclical poultry business, reducing overall earnings volatility.
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE398A01010/f07c52fe-8bf7-4edb-9bf7-8eb3112413ea.pdf
Historical Stock Returns for Venkys
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.74% | -1.74% | +3.51% | +5.11% | +4.58% | -45.10% |
How sustainable are the current margin expansions in the Poultry segment given the persistent pressure from rising feed costs?
Will Venky's continue to prioritize the high-margin Oilseed and Animal Health segments to further reduce reliance on the cyclical poultry business?
What is management's outlook on volume growth for FY27, considering the strong base established in Q1?


































